CVE-2025-52653

Cross Site Scripting vulnerability in the web application

Published Oct 3, 2025 CVSS 3.1 · 7.6 High EPSS < 1% KEV · Not listed
Description
HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.

Remediation

Vendor Solution

For customers using older version, mitigation path will include upgrade to version 6.7 which in turn will fix the vulnerability during upgrade process

Tracking

Sign in to view the affected projects.

Advisories

Source ID Title
EUVD EUVD EUVD-2025-32319 HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.
History
Type Values Removed Values Added
CPEs cpe:2.3:a:hcltech:dryice_myxalytics:6.6:*:*:*:*:*:*:*
Type Values Removed Values Added
First Time appeared Hcltech
Hcltech dryice Myxalytics
Vendors & Products Hcltech
Hcltech dryice Myxalytics
Type Values Removed Values Added
Metrics ssvc

{'options': {'Automatable': 'no', 'Exploitation': 'none', 'Technical Impact': 'partial'}, 'version': '2.0.3'}

Type Values Removed Values Added
Description HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.
Title Cross Site Scripting vulnerability in the web application
Weaknesses CWE-79
References
Metrics cvssV3_1

{'score': 7.6, 'vector': 'CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:L/A:H'}

Weaknesses

Sources

Status
PUBLISHED
Assigner
HCL
Published
Updated
Oct 3, 2025, 6:33 PM
Reserved
Jun 18, 2025, 2:03 PM
Status
Analyzed
Published
Oct 3, 2025, 6:15 PM
Modified
Oct 8, 2026, 10:10 PM